Need an oil spill lawyer? We will fight for you!
› $150,000,000 verdict in personal injury case
You’ve likely seen the commercials for Detrol. A woman is sitting in her doctor’s office and a woman-shaped figure similar to the ones seen on bathroom doors, is encouraging her to talk to her doctor about her frequent and sudden urges to go to the bathroom. The treatment has helped women find relief from overactive bladder.
The Food and Drug Administration (FDA) in partnership with OSI Pharmaceuticals Inc., and Genentech have issued a warning letter to healthcare professionals informing them of new safety information added to the WARNINGS AND PRECAUTIONS section of the cancer treatment drug Tarceva.
The new information, gathered from a clinical study and postmarketing reports, revealed sometimes fatal incidences of gastrointestinal perforation, bullous, blistering and exfoliative skin conditions including cases suggestive of Stevens Johnson Syndrome (SJS) and/or toxic epidermal necrolysis (TEN) and ocular disorders including corneal perforation or ulceration.
A cancer treatment drug approved by the Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia and non-Hodgkin’s lymphoma just last year has been linked to a serious adverse reaction known as Stevens Johnson Syndrome, or SJS, when used in conjunction with another medication.
A Chinese dermatologist believes he may have found a human protein that can lead to treatment for the severe and progressive skin disease, Stevens-Johnson Syndrome (SJS), according to the Taipei Times.
The U.S. Food and Drug Administration is investigating the possibility that phenytoin and fosphenytoin sodium increase the risk of serious skin reactions, such as Stevens Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN), according to FDA MedWatch. Phenytoin and fosphenytoin are used to control tonic-clonic (grand mal) and complex-partial seizures in epilepsy.
New reports from the Food and Drug Administration (FDA) and cancer patients have put Revlimid, an oral medicine given to patients with multiple myeloma, on a list of medications that could possibly cause Stevens Johnson Syndrome when used by itself or mixed with other drugs. Stevens Johnson syndrome is a serious, potentially life-threatening skin disease that can start with flu-like symptoms and eventually cause a rash that spreads and blisters.
Seven major pharmaceutical companies are banding together to develop genetic tests that predict which patients will have adverse side effects from drugs. The group, a nonprofit organization dubbed the International Serious Adverse Events Consortium (SAEC), will conduct two studies, one to look at drug-related liver toxicity and the other aimed at a rare drug-related skin condition called Stevens-Johnson syndrome.
![[ Beasley Allen Law Firm Logo ]](http://www.sjs-legal.com/wp-content/themes/system-unity/images/logo.png){kind=logo}